ITTN - Israel Tech Transfer Network :: Technology Opportunities

Combination of Alpha-1 Antitrypsin and Temporary T-Cell Depletion for the Treatment of Transplantation and Other Unwanted Immune Mediated Conditions

BGN - code: Patent Reference: IL 233647 EP 13755285.7 US 14/380,118

Researchers

Eli Lewis, of Clinical Biochemistry, Faculty of Health Sciences, Ben-Gurion University of the Negev

To learn more about this technology, please contact:

Ora Horovitz

Senior VP. Business Development

Send email

BGN Technologies Ltd. – Technology Transfer Company of Ben-Gurion University, POB 653, Beer-Sheva, 84105, Israel. Tel: +972-8-6236949 Fax: +972-8-627-6420

More Technologies by:

Eli Lewis (3)

Download page as PDF